Largest health care companies by total liabilities
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
Veradermics has the lowest figure of the 170 health care companies ranked by total liabilities, at CHF 7.7M, followed by Belite Bio (CHF 8.5M) and Oruka Therapeutics (CHF 14.1M). Figures as of 19 Nov 2026, 02:23 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 170
- Lowest
- VeradermicsCHF 7.7M
- Median
- CHF 2.6B
- Combined market value
- CHF 7.67T
- Countries
- 14
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | Total liabilities ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | VeradermicsMANE · Health Care | CHF 7.7M | CHF 4.4B | CHF 105.31 | 0.62% down | 233% up | ||
| 2 | Belite BioBLTE · Health Care | CHF 8.5M | CHF 5.4B | CHF 131.77 | 0.94% down | 31% up | ||
| 3 | Oruka TherapeuticsORKA · Health Care | CHF 14.1M | CHF 5.5B | CHF 80.75 | 0.60% down | 241% up | ||
| 4 | Edgewise TherapeuticsEWTX · Health Care | CHF 25.6M | CHF 3.8B | CHF 34.89 | 1.59% down | 88% up | ||
| 5 | Dianthus TherapeuticsDNTH · Health Care | CHF 31.6M | CHF 4B | CHF 70.83 | 3.45% down | 113% up | ||
| 6 | CG OncologyCGON · Health Care | CHF 32.9M | CHF 6B | CHF 67.47 | 1.34% up | 85% up | ||
| 7 | Protagonist TherapeuticsPTGX · Health Care | CHF 45.1M | CHF 7B | CHF 107.25 | 2.00% up | 46% up | ||
| 8 | HeartflowHTFL · Health Care | CHF 49.6M | CHF 3.4B | CHF 38.70 | 2.51% down | 73% up | ||
| 9 | Praxis Precision MedicinesPRAX · Health Care | CHF 50.4M | CHF 7.2B | CHF 257.40 | 0.04% up | 61% up | ||
| 10 | Spyre TherapeuticsSYRE · Health Care | CHF 52.8M | CHF 8.1B | CHF 85.57 | 8.15% up | 286% up | ||
| 11 | ErascaERAS · Health Care | CHF 59.9M | CHF 4.1B | CHF 11.61 | 0.94% down | 403% up | ||
| 12 | Summit TherapeuticsSMMT · Health Care | CHF 77.9M | CHF 7.1B | CHF 8.86 | 1.59% down | 36% down | ||
| 13 | ImmunovantIMVT · Health Care | CHF 88.1M | CHF 5.8B | CHF 27.98 | 0.12% down | 43% up | ||
| 14 | Definium TherapeuticsDFTX · Health Care | CHF 90.9M | CHF 3.4B | CHF 24.56 | 0.88% down | 169% up | ||
| 15 | Krystal BiotechKRYS · Health Care | CHF 96.3M | CHF 7.9B | CHF 265.96 | 5.62% up | 46% up | ||
| 16 | ABIVAXABVX · Health Care | CHF 120.8M | CHF 6.2B | CHF 70.70 | 2.11% up | 27% down | ||
| 17 | BillionToOneBLLN · Health Care | CHF 128.7M | CHF 3.7B | CHF 77.21 | 6.11% down | 0% up | ||
| 18 | Scholar Rock HoldingSRRK · Health Care | CHF 133.9M | CHF 4.9B | CHF 40.48 | 6.48% up | 14% up | ||
| 19 | Kymera TherapeuticsKYMR · Health Care | CHF 137.6M | CHF 8.7B | CHF 102.16 | 0.32% down | 87% up | ||
| 20 | Twist BioscienceTWST · Health Care | CHF 142.5M | CHF 6.7B | CHF 98.13 | 3.88% up | 340% up | ||
| 21 | Corcept TherapeuticsCORT · Health Care | CHF 159.3M | CHF 6.3B | CHF 57.18 | 3.25% down | 8% down | ||
| 22 | Kodiak SciencesKOD · Health Care | CHF 163.7M | CHF 5.4B | CHF 82.49 | 1.04% up | 396% up | ||
| 23 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | CHF 165.3M | CHF 6.3B | CHF 80.17 | 0.06% down | 126% up | ||
| 24 | Rhythm PharmaceuticalsRYTM · Health Care | CHF 177.3M | CHF 7B | CHF 100.40 | 2.08% up | 13% up | ||
| 25 | GlaukosGKOS · Health Care | CHF 200.2M | CHF 11.6B | CHF 196.58 | 4.18% down | 152% up | ||
| 26 | 10x GenomicsTXG · Health Care | CHF 206.7M | CHF 6.3B | CHF 48.13 | 1.37% up | 260% up | ||
| 27 | Adaptive BiotechnologiesADPT · Health Care | CHF 242.7M | CHF 3.9B | CHF 24.00 | 0.11% down | 88% up | ||
| 28 | Cogent BiosciencesCOGT · Health Care | CHF 254.1M | CHF 4.1B | CHF 23.46 | 0.14% down | 20% down | ||
| 29 | VaxcytePCVX · Health Care | CHF 267.5M | CHF 7.8B | CHF 49.36 | 1.48% down | 22% up | ||
| 30 | CRISPR TherapeuticsCRSP · Health Care | CHF 289.7M | CHF 3.3B | CHF 33.90 | 0.10% up | 21% down | ||
| 31 | GRAILGRAL · Health Care | CHF 290.3M | CHF 3.9B | CHF 86.11 | 3.57% down | 20% up | ||
| 32 | PenumbraPEN · Health Care | CHF 336.5M | CHF 10.7B | CHF 270.40 | 0.47% up | 13% up | ||
| 33 | TG TherapeuticsTGTX · Health Care | CHF 350.2M | CHF 8.4B | CHF 55.77 | 5.44% up | 107% up | ||
| 34 | Roivant SciencesROIV · Health Care | CHF 351.1M | CHF 23.7B | CHF 32.67 | 0.05% up | 90% up | ||
| 35 | Bio-TechneTECH · Health Care | CHF 403.6M | CHF 9.6B | CHF 61.36 | 0.17% up | 26% up | ||
| 36 | Travere TherapeuticsTVTX · Health Care | CHF 413.6M | CHF 4.1B | CHF 42.37 | 1.68% down | 44% up | ||
| 37 | Mirum PharmaceuticalsMIRM · Health Care | CHF 445.4M | CHF 5.1B | CHF 78.01 | 0.59% up | 31% up | ||
| 38 | Ligand PharmaceuticalsLGND · Health Care | CHF 458.3M | CHF 5B | CHF 251.94 | 1.67% up | 43% up | ||
| 39 | Caris Life SciencesCAI · Health Care | CHF 462.5M | CHF 4.7B | CHF 16.45 | 2.21% down | 17% down | ||
| 40 | ChemedCHE · Health Care | CHF 471.3M | CHF 6B | CHF 461.11 | 0.01% down | 27% up | ||
| 41 | Axsome TherapeuticsAXSM · Health Care | CHF 507.3M | CHF 5.9B | CHF 113.02 | 1.43% down | 7% down | ||
| 42 | Madrigal PharmaceuticalsMDGL · Health Care | CHF 554M | CHF 7.8B | CHF 335.75 | 5.67% down | 24% down | ||
| 43 | AlkermesALKS · Health Care | CHF 563.1M | CHF 6.6B | CHF 39.51 | 3.08% up | 58% up | ||
| 44 | LifeStance Health GroupLFST · Health Care | CHF 576M | CHF 4.4B | CHF 11.61 | 2.82% down | 129% up | ||
| 45 | ExelixisEXEL · Health Care | CHF 576.1M | CHF 14.1B | CHF 57.60 | 0.31% down | 63% up | ||
| 46 | NateraNTRA · Health Care | CHF 578.5M | CHF 35.4B | CHF 244.17 | 0.71% up | 32% up | ||
| 47 | Revolution MedicinesRVMD · Health Care | CHF 610M | CHF 29.2B | CHF 134.80 | 1.76% down | 131% up | ||
| 48 | Globus MedicalGMED · Health Care | CHF 615.3M | CHF 7.9B | CHF 59.49 | 0.77% up | 16% down | ||
| 49 | Legend BiotechLEGN · Health Care | CHF 617M | CHF 2.7B | CHF 13.71 | 0.87% up | 42% down | ||
| 50 | United TherapeuticsUTHR · Health Care | CHF 661.1M | CHF 20.7B | CHF 486.94 | 1.16% down | 23% up | ||
| 51 | RepligenRGEN · Health Care | CHF 711.5M | CHF 9.3B | CHF 145.63 | 6.47% up | 5% up | ||
| 52 | Arrowhead PharmaceuticalsARWR · Health Care | CHF 743.8M | CHF 5.1B | CHF 36.36 | 0.28% up | 10% up | ||
| 53 | ImmunityBioIBRX · Health Care | CHF 844.7M | CHF 6B | CHF 5.65 | 7.03% up | 193% up | ||
| 54 | MiniMed GroupMMED · Health Care | CHF 859.4M | CHF 4B | CHF 14.33 | 4.44% down | 4% down | ||
| 55 | West Pharmaceutical ServicesWST · Health Care | CHF 922.7M | CHF 23.7B | CHF 340.76 | 2.44% down | 61% up | ||
| 56 | Merit Medical SystemsMMSI · Health Care | CHF 929.1M | CHF 4.3B | CHF 72.48 | 1.70% up | 1% up | ||
| 57 | Lantheus HoldingsLNTH · Health Care | CHF 959.5M | CHF 5.6B | CHF 86.03 | 0.20% up | 93% up | ||
| 58 | MSA SafetyMSA · Health Care | CHF 1B | CHF 5.8B | CHF 149.66 | 2.67% up | 11% up | ||
| 59 | HealthEquityHQY · Health Care | CHF 1.1B | CHF 6.8B | CHF 82.07 | 4.45% down | 2% down | ||
| 60 | argenxARGX · Health Care | CHF 1.1B | CHF 49.9B | CHF 793.87 | 0.66% down | 4% up | ||
| 61 | Neurocrine BiosciencesNBIX · Health Care | CHF 1.2B | CHF 13.9B | CHF 137.36 | 1.84% down | 20% up | ||
| 62 | LivaNovaLIVN · Health Care | CHF 1.2B | CHF 4.4B | CHF 79.74 | 2.85% up | 71% up | ||
| 63 | BioMarin PharmaceuticalBMRN · Health Care | CHF 1.3B | CHF 10B | CHF 51.81 | 4.99% up | 11% up | ||
| 64 | Medpace HoldingsMEDP · Health Care | CHF 1.3B | CHF 15.3B | CHF 545.58 | 0.95% down | 10% up | ||
| 65 | InsmedINSM · Health Care | CHF 1.3B | CHF 22.2B | CHF 101.04 | 1.69% down | 40% down | ||
| 66 | HaemoneticsHAE · Health Care | CHF 1.3B | CHF 4.7B | CHF 103.62 | 1.60% up | 61% up | ||
| 67 | Hims & Hers HealthHIMS · Health Care | CHF 1.4B | CHF 3.4B | CHF 14.38 | 2.85% down | 51% down | ||
| 68 | Ascendis PharmaASND · Health Care | CHF 1.4B | CHF 15B | CHF 228.00 | 0.32% down | 28% up | ||
| 69 | InsuletPODD · Health Care | CHF 1.4B | CHF 8.2B | CHF 118.06 | 3.69% down | 58% down | ||
| 70 | IDEXX LaboratoriesIDXX · Health Care | CHF 1.5B | CHF 46.4B | CHF 589.10 | 1.19% up | 1% down | ||
| 71 | IncyteINCY · Health Care | CHF 1.5B | CHF 20.3B | CHF 99.35 | 1.08% down | 18% up | ||
| 72 | CytokineticsCYTK · Health Care | CHF 1.8B | CHF 6B | CHF 43.28 | 0.64% down | 20% down | ||
| 73 | Guardant HealthGH · Health Care | CHF 1.8B | CHF 16.6B | CHF 122.41 | 1.30% up | 44% up | ||
| 74 | Dr. Reddy's LaboratoriesRDY · Health Care | CHF 1.8B | CHF 10.5B | CHF 12.63 | 1.28% up | 5% up | ||
| 75 | Option Care HealthOPCH · Health Care | CHF 1.8B | CHF 4B | CHF 26.74 | 0.25% up | 14% up | ||
| 76 | Align TechnologyALGN · Health Care | CHF 1.8B | CHF 9.7B | CHF 138.29 | 0.31% up | 22% up | ||
| 77 | ResMedRMD · Health Care | CHF 2B | CHF 28.8B | CHF 204.62 | 2.00% up | 3% down | ||
| 78 | RadNetRDNT · Health Care | CHF 2B | CHF 4.8B | CHF 60.57 | 4.14% down | 7% down | ||
| 79 | Concentra Group Holdings ParentCON · Health Care | CHF 2.1B | CHF 4.5B | CHF 35.41 | 0.94% down | 120% up | ||
| 80 | Halozyme TherapeuticsHALO · Health Care | CHF 2.1B | CHF 9.2B | CHF 80.80 | 0.18% down | 37% up | ||
| 81 | QiagenQGEN · Health Care | CHF 2.1B | CHF 8.6B | CHF 41.80 | 0.38% down | 12% up | ||
| 82 | WatersWAT · Health Care | CHF 2.1B | CHF 77.3B | CHF 393.12 | 3.63% up | 20% up | ||
| 83 | Intuitive SurgicalISRG · Health Care | CHF 2.1B | CHF 123.1B | CHF 355.04 | 2.23% down | 24% down | ||
| 84 | BridgeBio PharmaBBIO · Health Care | CHF 2.5B | CHF 12.8B | CHF 65.80 | 1.58% up | 17% up | ||
| 85 | Ionis PharmaceuticalsIONS · Health Care | CHF 2.6B | CHF 3.8B | CHF 23.10 | 1.59% up | 64% down | ||
| 86 | BioNTechBNTX · Health Care | CHF 2.6B | CHF 17.4B | CHF 70.22 | 1.89% down | 16% down | ||
| 87 | PTC TherapeuticsPTCT · Health Care | CHF 2.6B | CHF 4.2B | CHF 50.80 | 0.22% down | 20% down | ||
| 88 | Bio-Rad LaboratoriesBIO · Health Care | CHF 2.6B | CHF 8.4B | CHF 312.21 | 3.34% up | 18% up | ||
| 89 | Ensign GroupENSG · Health Care | CHF 2.7B | CHF 9B | CHF 154.33 | 1.63% down | 4% up | ||
| 90 | Edwards LifesciencesEW · Health Care | CHF 2.8B | CHF 51B | CHF 88.75 | 0.19% down | 23% up | ||
| 91 | STERISSTE · Health Care | CHF 3B | CHF 21.3B | CHF 218.93 | 0.84% up | 1% up | ||
| 92 | DexComDXCM · Health Care | CHF 3B | CHF 26B | CHF 69.60 | 0.59% up | 37% up | ||
| 93 | Amneal PharmaceuticalsAMRX · Health Care | CHF 3.1B | CHF 6.4B | CHF 18.45 | 3.60% up | 83% up | ||
| 94 | ModernaMRNA · Health Care | CHF 3.1B | CHF 67.2B | CHF 165.98 | 4.84% down | 755% up | ||
| 95 | BrukerBRKR · Health Care | CHF 3.1B | CHF 8.1B | CHF 53.35 | 3.10% up | 41% up | ||
| 96 | Mettler-Toledo InternationalMTD · Health Care | CHF 3.2B | CHF 29.1B | CHF 1,465.24 | 1.42% up | 22% up | ||
| 97 | Encompass HealthEHC · Health Care | CHF 3.2B | CHF 11.2B | CHF 113.80 | 2.14% down | 23% up | ||
| 98 | TeleflexTFX · Health Care | CHF 3.2B | CHF 5.5B | CHF 139.88 | 3.95% up | 51% up | ||
| 99 | BeOne MedicinesONC · Health Care | CHF 3.2B | CHF 38.9B | CHF 340.40 | 2.34% down | 17% up | ||
| 100 | IlluminaILMN · Health Care | CHF 3.3B | CHF 26.8B | CHF 177.13 | 3.65% up | 69% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total liabilities is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Where a company reports no total-liabilities line, it is worked out as assets less equity. Sums are converted from US dollars at today's exchange rate (1 USD = 0.8434 CHF).
Questions and answers
Which health care companies have the lowest total liabilities?
Veradermics (CHF 7.7M), Belite Bio (CHF 8.5M) and Oruka Therapeutics (CHF 14.1M) have the lowest total liabilities of the 170 health care companies ranked here as of 19 Nov 2026, 02:23 UTC.
How many health care companies are in this ranking?
170 are ranked by total liabilities.
What are these health care companies worth together?
The 170 health care companies ranked by total liabilities have a combined market value of CHF 7.67T as of 19 Nov 2026, 02:23 UTC.
What does ranking by total liabilities measure?
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest health care companies by total liabilities”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=total-liabilities
Underlying data: Yahoo Finance; SEC EDGAR.